Augmented expression of programmed death‐1 in both neoplastic and non‐neoplastic CD4+ T‐cells in adult T‐cell leukemia/lymphoma

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Cancer

• Publication date

  2007-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.23042PMID 17721918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulatory T‐cell function of adult T‐cell leukemia/lymphoma cells

  2007cited by this paper
• PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma

  2007cited by this paper
• Upregulation of PD-1 Expression on HIV-Specific CD8+ T Cells Leads to Reversible Immune Dysfunction

  2007cited by this paper
• PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

  2006cited by this paper
• PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

  2006cited by this paper
• Delineation of immunoregulatory properties of adult T-cell leukemia cells

  2006cited by this paper
• Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells.

  2006cited by this paper
• Regulated Compartmentalization of Programmed Cell Death-1 Discriminates CD4+CD25+ Resting Regulatory T Cells from Activated T Cells1

  2006cited by this paper
• Programmed Death-1 (PD-1) is a Marker of Germinal Center-associated T Cells and Angioimmunoblastic T-Cell Lymphoma

  2006influential reference
• Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

  2006cited by this paper
• Production of Thymus and Activation-Regulated Chemokine and Macrophage-Derived Chemokine by CCR4+ Adult T-Cell Leukemia Cells

  2005cited by this paper
• Possible origin of adult T‐cell leukemia/lymphoma cells from human T lymphotropic virus type‐1‐infected regulatory T cells

  2005cited by this paper
• B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 Expression

  2004cited by this paper
• Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity

  2004cited by this paper
• Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis.

  2003cited by this paper
• What's the difference between CD80 and CD86?

  2003cited by this paper
• Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.

  2003cited by this paper
• B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.

  2003cited by this paper
• Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production 1

  2003cited by this paper
• Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells.

  2002cited by this paper
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

  2002cited by this paper
• Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength.

  2002cited by this paper
• PD-1: an inhibitory immunoreceptor involved in peripheral tolerance.

  2001cited by this paper
• CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.

  2001cited by this paper
• PD-L2 is a second ligand for PD-1 and inhibits T cell activation

  2001cited by this paper
• PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

  2001cited by this paper
• Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).

  2000cited by this paper
• Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

  2000cited by this paper
• Human retroviruses: their role in cancer.

  1999cited by this paper
• CTLA-4 ligation blocks CD28-dependent T cell activation [published erratum appears in J Exp Med 1996 Jul 1;184(1):301]

  1996cited by this paper
• Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

  1996cited by this paper
• CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

  1995cited by this paper
• Structure and chromosomal localization of the human PD-1 gene (PDCD1).

  1994cited by this paper
• Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma

  1991cited by this paper
• Immunodeficiency in preclinical smoldering adult T-cell leukemia.

  1988cited by this paper
• Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

  1980cited by this paper
• Adult T-cell leukemia: clinical and hematologic features of 16 cases.

  1977cited by this paper

• Immune Checkpoint Molecules in Hodgkin Lymphoma and Other Hematological Malignancies

  2025cites this paper
• Direct Inhibitory Effect of HTLV‐1‐Infected T Cells on the Production of Anti‐Ro/SS‐A Antibody by B Cells from Patients with Sjögren's Syndrome

  2025cites this paper
• CD28 Superfamily Costimulatory Molecules in Chronic Pain: Focus on Immunomodulation

  2025cites this paper
• Lomitapide repurposing for treatment of malignancies: A promising direction

  2024cites this paper
• Efficacy of programmed cell death 1 inhibitor maintenance after chimeric antigen receptor T cells in patients with relapsed/refractory B-cell non-Hodgkin-lymphoma

  2024cites this paper
• A Case of Prostate Cancer with Multiple Bone Metastases in which Standard Treatment was Ineffective but Remission was Achieved with Amplified Natural Killer Cell Therapy, and the Usefulness of PD-L1 Positivity as a Biomarker for Solid Tumors

  2024cites this paper
• cGAS-STING and PD1/PDL-1 pathway in breast cancer: a window to new therapies

  2024cites this paper
• PD-L1 and PD-1 in Immune Regulation and Their Implications in Blood Cancers

  2024cites this paper
• Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma

  2022cites this paper
• Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma

  2022cites this paper
• HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system

  2022cites this paper
• Effectiveness of Amplified Natural Killer (ANK) Therapy for Adult T-cell Leukemia/Lymphoma (ATL) and Future Prospects of ANK Therapy.

  2022cites this paper
• PD-1 and PD-L1 inhibitors foster the progression of adult T-cell Leukemia/Lymphoma.

  2021cites this paper
• Immunotherapy and Immunomodulation in Myeloproliferative Neoplasms.

  2021cites this paper
• CCR4 as a Therapeutic Target for Cancer Immunotherapy

  2021cites this paper
• Blockade of LIRs as a new approach for diagnosis and treatment of ATLL malignancy

  2021cites this paper
• Clinical significance of PD-1 and PD-L1 molecules in patients with diffuse large B-cell lymphoma, not otherwise specified: Correlation with clinical and pathological findings.

  2021cites this paper
• Phenotypic and Functional Analyses Guiding Combination Immune Checkpoint Immunotherapeutic Strategies in HTLV-1 Infection

  2021cites this paper
• Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives

  2021cites this paper
• Immunopathogenesis and Cellular Interactions in Human T-Cell Leukemia Virus Type 1 Associated Myelopathy/Tropical Spastic Paraparesis

  2020influential citation
• HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina

  2020cites this paper
• The roles of programmed death ligand 1 in virus-associated cancers.

  2020cites this paper
• Immune checkpoints in hematologic malignancies: What made the immune cells and clinicians exhausted!

  2020influential citation
• Perspectives on the Role of T Cell Negative Immune Checkpoint Receptors in Health and Disease

  2020cites this paper
• Cutaneous manifestations of adult T-cell leukemia/lymphoma.

  2020cites this paper
• Identification of a monoclonal antibody that targets PD-1 in a manner requiring PD-1 Asn58 glycosylation

  2019cites this paper
• Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.

  2019cites this paper
• New Therapies and Immunological Findings in Melanoma and Other Skin Cancers

  2019cites this paper
• Clinical and histopathological significance of PD-1 expression in cutaneous lesions of adult T-cell leukemia-lymphoma.

  2019cites this paper
• The Roles of Coinhibitory Receptors in Pathogenesis of Human Retroviral Infections

  2018cites this paper
• Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity

  2018cites this paper
• Biomarkers for checkpoint inhibition in hematologic malignancies.

  2018cites this paper
• PD-1-PD-L1 immune-checkpoint blockade in malignant lymphomas

  2018cites this paper
• Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases

  2018cites this paper
• Identification of immuno-inhibitory molecules in Mongolian native cattle and yak

  2018cites this paper
• Studies on Immunoinhibitory Receptor and Viral Antigen Expression in Bovine Leukemia Virus Infection [an abstract of entire text]

  2018influential citation
• Successful Amplified-Natural-Killer Cell (ANK) Therapy Administered to a Patient with Smoldering Adult T-Cell Leukemia in Acute Crisis

  2018cites this paper
• New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma

  2018cites this paper
• immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies

  2017cites this paper
• HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors

  2017cites this paper
• Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.

  2017cites this paper
• Expression of programmed death‐1 in cutaneous extranodal natural killer/T‐cell lymphoma and its effect on clinical findings and biological behaviour

  2017cites this paper
• Immunotherapy in adult acute leukemia.

  2017cites this paper
• Correction: HTLV-1 bZIP Factor Enhances T-cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors

  2017cites this paper
• The role of anti-PD-1 and anti-PD-L1 agents in the treatment of diffuse large B-cell lymphoma: The future is now.

  2017cites this paper
• Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics

  2017cites this paper
• Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies

  2017cites this paper
• Adult T-Cell Leukemia/Lymphoma

  2017cites this paper
• Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies

  2016influential citation
• Antibody-mediated molecular-targeted therapy for adult T-cell leukemia: Recent progress and future challenges in the treatment of cancers

  2016cites this paper
• Combinaison d'un antagoniste de pd-1 et d'éribuline dans le traitement du cancer

  2016cites this paper
• PD1/PD1L pathway, HLA-G and T regulatory cells as new markers of immunosuppression in cancers.

  2016cites this paper
• Crystal clear: visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies

  2016cites this paper
• Blocking tumor escape in hematologic malignancies: the anti-PD-1 strategy.

  2015cites this paper
• Releasing the Brake on the Immune System: The PD-1 Strategy for Hematologic Malignancies.

  2015cites this paper
• Programmed cell death-1 inhibition in lymphoma.

  2015cites this paper
• Human T‐lymphotropic virus 1 (HTLV‐1)‐associated lichenoid dermatitis induced by CD8+ T cells in HTLV‐1 carrier, HTLV‐1‐associated myelopathy/tropical spastic paraparesis and adult T‐cell leukemia/lymphoma

  2015cites this paper
• Use of PD-1, CD1a, and S-100 in Differentiating Pseudolymphomatous Folliculitis and Indolent Primary Cutaneous B-Cell Lymphomas

  2015cites this paper
• T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment

  2015cites this paper
• Programmed death 1 and B and T lymphocyte attenuator immunoreceptors and their association with malignant T‐lymphoproliferative disorders: brief review

  2014cites this paper
• Pidilizumab in the treatment of diffuse large B-cell lymphoma

  2014cites this paper
• Identification and characterization of bovine programmed death‐ligand 2

  2014cites this paper
• Programmed death-1 (PD-1) polymorphisms in Chinese patients with esophageal cancer.

  2014cites this paper
• Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.

  2014cites this paper
• Skin manifestations of adult T‐cell leukemia/lymphoma: Clinical, cytological and immunological features

  2014cites this paper
• Anticorps anti-pd-1 et son utilisation

  2014cites this paper
• Utility of CD279/PD-1 immunohistochemistry in the evaluation of benign and neoplastic T-cell-rich bone marrow infiltrates.

  2014cites this paper
• Traitement du cancer avec une combinaison d'un antagoniste de pd-1 et du dinaciclib

  2014cites this paper
• Identification and Quantification of Total Coumarins from Urtica dentata Hand and Its Roles in Promoting Immune Tolerance via TLR4-Mediated Dendritic Cell Immaturation

  2013cites this paper
• The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies

  2013cites this paper
• Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro

  2013cites this paper
• Lichen planus-like lesions as the first manifestation of adult T-cell leukaemia/lymphoma.

  2013cites this paper
• CD164 and FCRL3 are highly expressed on CD4+CD26-T cells in Sézary syndrome patients

  2013cites this paper
• The PD-1 / PD-L 1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia

  2013cites this paper
• The difficulties in defining follicular T helper phenotype in cutaneous lymphomas.

  2013cites this paper
• Acute generalized exanthematous pustulosis with histopathologic findings of lymphomatoid drug reaction.

  2013influential citation
• The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia

  2012cites this paper
• Znaczenie receptora programowanej śmierci 1 oraz jego ligandów w układzie immunologicznym oraz nowotworach

  2012cites this paper
• Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases.

  2012cites this paper
• Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Marek’s disease virus

  2012cites this paper
• Programmed Death-1 and Its Ligand Are Novel Immunotolerant Molecules Expressed on Leukemic B Cells in Chronic Lymphocytic Leukemia

  2012cites this paper
• CD4/CD8 double negative mycosis fungoides with PD-1 (CD279) expression--a disease of follicular helper T-cells?

  2012cites this paper
• HTLV‐1‐associated infective dermatitis: updates on the pathogenesis

  2012cites this paper
• Severe mental retardation and recessive congenital methemoglobinemia in three Indian patients: Compound heterozygous for NADH‐cytochrome b5 reductase gene mutations

  2011cites this paper
• Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade

  2011cites this paper
• Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma

  2011cites this paper
• Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome

  2011cites this paper
• An essential role for programmed death-1 in the control of autoimmunity: implications for the future of hematopoietic stem cell transplantation.

  2011cites this paper
• Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma.

  2011cites this paper
• Structure and function of programmed death (PD) molecules.

  2010cites this paper
• Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma

  2010cites this paper
• Molecular cloning and expression analysis of bovine programmed death‐1

  2010influential citation
• Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression.

  2010cites this paper
• Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?

  2010cites this paper
• Partial restoration of T‐cell function in aged mice by in vitro blockade of the PD‐1/ PD‐L1 pathway

  2010cites this paper
• PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients

  2009cites this paper
• Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell Markers

  2009influential citation
• Peripheral T-cell Lymphoma With Follicular T-cell Markers

  2008cites this paper
• Functional diversity of T-cell subpopulations in subacute and chronic hypersensitivity pneumonitis.

  2008cites this paper
• Scabies superimposed on skin lesions of adult T‐cell leukemia/lymphoma: case report and literature review

  2008cites this paper